RxDoctor Payments Data

Adam Wray, DO

Dermatology · Blackfoot, IDNPI 1902952930

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,232 of the $1,624 with a category attached, or 75.9%. 16 manufacturers reported payments, led by AbbVie at 24.8% of the total. That places this record below the midpoint for dermatology clinicians in ID, where the typical reported total is $2,238.

$1,624in general payments, 2019–2025

Across 73 payments — averaging $22.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$402
  • Johnson & Johnson$318
  • Kerecis Limited$268
  • Regeneron Healthcare Solutions, Inc.$155
  • Axonics, Inc.$109
  • Pfizer$92
  • plus $281 from 10 others
$4,750in research payments, 2019–2025

Across 4 payments — averaging $1187.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$5K

What the payments were for

  • Food & beverage$1,23276%
  • Education$39224%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,624 in reported general payments places this provider in the 40th percentile of 52 dermatology providers in Idaho.

See all dermatology providers in Idaho

Medicare billing

Part B allowed, 2024
$173,865
Medicare patients
449
Services billed
2,271

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab13$86,180
Fluorouracil34$5,061
Metronidazole33$4,369
Clobetasol Propionate51$1,521
Minocycline Hcl36$1,389
Cephalexin291$1,307
Ketoconazole110$1,253
Fluconazole49$1,156
Doxycycline Hyclate44$987
Betamethasone Dipropionate17$953
Triamcinolone Acetonide103$764
Fluocinonide16$681
Clindamycin Phosphate13$476
Mupirocin47$409
Mometasone Furoate18$331

Paid to pharmacies, not to this prescriber.

Other dermatology in Blackfoot

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →